SCM
DYN icon

Sterling Capital Management’s Dyne Therapeutics DYN Stock Holding History

Sterling Capital Management’s Portfolio DYN Stock Details DYN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$59.5K Sell
3,281
-1,885
-36% -$32.5K ﹤0.01% 1573
2025
Q4 		$101K Sell
5,166
-45
-0.9% -$852 ﹤0.01% 1526
2025
Q3 		$65.9K Buy
5,211
+3,414
+190% +$38.9K ﹤0.01% 1673
2025
Q2 		$17.1K Buy
1,797
+1,714
+2,065% +$18.9K ﹤0.01% 1850
2025
Q1 		$868 Hold
83
– – ﹤0.01% 2858
2024
Q4 		$1.96K Hold
83
– – ﹤0.01% 2793
2024
Q3 		$2.98K Buy
+83
New +$3.3K ﹤0.01% 1997

Other funds holding DYN

T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
AVLSA
Atlas Venture Life Science Advisors Cambridge, Massachusetts $790M AUM 223.66% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
OAG
Orbis Allan Gray Hamilton, Bermuda $23.7B AUM 65.43% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
FIS
FCPM III Services Naarden, Netherlands $722M AUM 73.61% 1-Year Est. Return

Sterling Capital Management's DYN Position: Q1 2026 in Review

Sterling Capital Management reduced its Dyne Therapeutics (DYN) stake by 36% in Q1 2026, selling an estimated $32.5K and leaving 3,281 shares worth $59.5K. The position accounts for ﹤0.01% of the portfolio, ranked #1573.

Sterling Capital Management first reported a position in DYN in Q3 2024 and has held it in 7 quarters since. The position peaked at $101K in Q4 2025. 227 funds tracked by Wall St. Rank hold DYN as of Q1 2026.

  • Sterling Capital Management held 3,281 shares of Dyne Therapeutics worth $59.5K as of Q1 2026.
  • Sterling Capital Management sold 1,885 Dyne Therapeutics shares in Q1 2026, an estimated $32.5K.
  • Dyne Therapeutics made up ﹤0.01% of Sterling Capital Management's portfolio in Q1 2026, its #1573 holding.
  • Sterling Capital Management first reported a position in Dyne Therapeutics in Q3 2024 and has held it in 7 quarters since.
  • Sterling Capital Management's Dyne Therapeutics position peaked at $101K in Q4 2025.
  • 227 funds tracked by Wall St. Rank held Dyne Therapeutics as of Q1 2026.

Based on Sterling Capital Management's 13F filing for Q1 2026, filed 22 Apr 2026.